REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study.
Ma C, Panaccione R, Xiao Y, Khandelwal Y, Murthy SK, Wong ECL, Narula N, Tsai C, Peerani F, Reise-Filteau M, Bressler B, Starkey SY, Loomes D, Sedano R, Jairath V, Bessissow T; Canadian IBD Research Consortium.
Ma C, et al. Among authors: khandelwal y.
Am J Gastroenterol. 2023 May 1;118(5):861-871. doi: 10.14309/ajg.0000000000002129. Epub 2022 Dec 14.
Am J Gastroenterol. 2023.
PMID: 36580497
Free PMC article.